Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avectas

Avectas
2011 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of cell engineering technology designed to offer vector-free intracellular delivery. The company's cell engineering technology delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of cell types including T cells for immuno-oncology applications, enabling drug developers to manufacture potent engineered cell therapies at therapeutic volumes, with high efficiency and with minimal cell disruption.

Website
Formerly Known As
Profector Life Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 3rd Floor Eolas Building, MaynoothWorks
  • Maynooth University, County Kildare
  • Dublin
  • Ireland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avectas’s full profile, request a free trial.

Avectas Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-Apr-2019 $10M 0000 Completed Startup
3. Grant 01-Feb-2018 00.000 Completed Startup
2. Corporate 05-Jan-2015 Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Avectas Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avrobio Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Avectas Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Seamus Mulligan Angel (individual) Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Adapt Pharma Corporation Minority 000 0000 000000 0
Enterprise Ireland Government Minority 000 0000 000000 0
MaynoothWorks Accelerator/Incubator Minority 000 0000 000000 0

Avectas Executive Team (4)

Name Title Board
Seat
Contact
Info
Michael Maguire Co-Founder, Director & Chief Executive Officer
Shirley O'Dea Ph.D Co-Founder, Director & Chief Scientific Officer
Mary Martin Ph.D Chairwoman

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Avectas Board Members (5)

Name Representing Role Since Contact
Info
Ann Brady Avectas Board Member 000 0000
Barry Leonard Avectas Board Member 000 0000
Barry Wohl Avectas Board Member 000 0000
Eunan Maguire Adapt Pharma Board Member 000 0000
Mary Martin Ph.D Avectas Chairwoman 000 0000